The World Health Organization recognizes cancer as a major health concern, disproportionately impacting LMICs. CancerAI, an innovative solution utilizing generative AI, aids medical professionals in making informed clinical decisions and predicting optimal cancer treatments for patients.
OncoAi enhances AI in cancer care by providing doctors with real-time information on approved and available medicines in their country, thus widening the reach of essential information in LMICs. OncoAi can improve the quality of cancer care by offering personalized treatment recommendations tailored to a patient's specific condition and the medicines available within their country. Additionally, OncoAi evaluates the effectiveness of prescribed treatments.
See the results of our study of 20 Breast Cancer patients @BHU hospital presented at ESSO 44 Sweden, Oct - 2025.
If you want to try out the CancerAI chatbot and run a trial, please share your email in our chat agent below. We will be in touch and enable you to try and test it out in your country!
SocialgoodAi, a US nonprofit developing responsible AI tools for equitable cancer care, is pioneering the use of AI in cancer care. This includes the development of a CancerAI chatbot aimed at supporting patients. The early clinical validation of these tools was conducted in collaboration with clinicians affiliated with Banaras Hindu University, and the research has been presented at an international oncology conference, showcasing the potential of generative AI in improving cancer treatment outcomes.
Dr S.K. Gupta from IMS-BHU will work with you and your primary Dr to provide 2nd Opinion.
You complete the Consent form
You share all the reports
Dr Gupta with the help of Onco AI will provide a 2nd Opinion
Cancer experts, Surgeons, Oncologists from IMS-BHU with 25+ years of experience.
Real-time Access to Essential Medications:
Ensuring patients benefit from timely access to approved and available medications within their country.
Personalized Treatment:
Offering personalized treatment recommendations based on a patient's unique circumstances and the available resources within their country to optimize treatment outcome.
Healthcare Professionals:
Providing a reliable source of information on approved and available medications and treatment protocols, enabling them to make informed decisions about patient care.
Researchers:
Analyze large datasets to identify patterns and trends, accelerating the development of new cancer treatments and optimizing clinical trial protocols based on AI-generated insights.
The World Health Organization recognizes cancer as a major health concern, disproportionately impacting LMICs. CancerAI, an innovative solution utilizing generative AI, aids medical professionals in making informed clinical decisions and predicting optimal cancer treatments for patients.
SocialgoodAi, a US nonprofit developing responsible AI tools for equitable cancer care, is pioneering the use of AI in cancer care. The early clinical validation of these tools was conducted in collaboration with clinicians affiliated with Banaras Hindu University, and the research has been presented at an international oncology conference.
We offer Open/Free Access: Onco AI is offered free of cost to new, junior, and practicing clinicians in underserved regions. Our products utilize cutting-edge generative AI and the latest LLMs, which are specifically trained and fine-tuned for LMIC and adhere to established guidelines from NCCN and ICMR and other international guidelines for Cancer care.
SocialgoodAi is founded by BHU-IIT Alumni, Tejpal Chadha, Ajit Singh, and Breast Cancer Experts from IMS-BHU, Dr. S.K. Gupta and Alumni Rajesh Kanango, focusing on innovative solutions like the CancerAI chatbot to enhance AI in cancer care through the use of generative AI. Send email to admin@socialgoodai.org to contact us.
Socialgoodai is a 501(c)(3) nonprofit organization focused on harnessing the power of AI in cancer care. With Tax ID: 39-3041270. We are committed to providing innovative solutions such as the CancerAI chatbot to Oncologists, which utilizes generative AI to enhance patient outcomes in low medium income countries.
